(Press-News.org) NORMAN, Okla. – Move over money, a new currency is helping make the world go round. As increasing volumes of data become accessible, transferable and, therefore, actionable, information is the treasure companies want to amass. To protect this wealth, organizations use cryptography, or coded messages, to secure information from "technology robbers." This group of hackers and malware creators increasingly is becoming more sophisticated at breaking encrypted information, leaving everyone and everything, including national security and global commerce, at risk.
But the threat to information breach may be drastically reduced as a result of a technology breakthrough that combines quantum mechanics and cryptography. University of Oklahoma electrical and computer engineering professor Pramode Verma and his colleagues Professor Subhash Kak from Oklahoma State University and Professor Yuhua Chen from the University of Houston have, at the OU-Tulsa College of Engineering labs, demonstrated a novel technique for cryptography that offers the potential of unconditional security.
"Unfortunately, all commercial cryptography techniques used today are based on what is known as computational security," Verma said. "This means that as computing power increases, they are increasingly susceptible to brute force and other attacks based on mathematical principles that can recover information without knowing the key to decode the information." Cryptography techniques based on quantum mechanics are not susceptible to such attacks under any imaginable condition.
In 2006, Kak postulated a theory known as the three-stage protocol, which relies on the unpredictability of photons to ensure hackers can't locate or replicate the information used to transmit information. The first laboratory demonstration of Kak's concept took place at the College of Engineering labs at the OU-Tulsa Schusterman Center. This is an important step toward the widespread adoption of Kak's discovery and may lead to a future in which, Verma said, "Basically, no matter how long or how hard they try, technology robbers can no longer decrypt or hack transmitted information."
This breakthrough has widespread economic and global applications. Quantum cryptography has been used in rare instances, primarily Swiss banks, but is limited by its short transmission distance and slow speed. Verma and his research team's technology demonstration suggest the potential for breaking those barriers.
"As we continue to test this promising method of quantum cryptology, we can demonstrate its value and accelerate the adoption in the business world," Verma said.
The widespread application of quantum cryptology could someday ensure that technology robbers won't be able to break into the information bank.
### END
OU researchers implement a multi-photon approach in quantum cryptography
Information breach may be drastically reduced as a result of a technology breakthrough
2012-10-04
ELSE PRESS RELEASES FROM THIS DATE:
Anthropologist finds evidence of hominin meat eating 1.5 million years ago
2012-10-04
DENVER (Oct. 4, 2012) – A skull fragment unearthed by anthropologists in Tanzania shows that our ancient ancestors were eating meat at least 1.5 million years ago, shedding new light into the evolution of human physiology and brain development.
"Meat eating has always been considered one of the things that made us human, with the protein contributing to the growth of our brains," said Charles Musiba, Ph.D., associate professor of anthropology at the University of Colorado Denver, who helped make the discovery. "Our work shows that 1.5 million years ago we were not opportunistic ...
'Humanized' mice advance study of rheumatoid arthritis
2012-10-04
Researchers at Northwestern University Feinberg School of Medicine have developed the first animal model that duplicates the human response in rheumatoid arthritis (RA), an important step that may enable scientists to discover better medicines to treat the disease.
Corresponding and senior author Harris Perlman, associate professor of rheumatology at Feinberg, introduced his team's new prototype mouse model in a recent online issue of the Journal of Translational Medicine.
"This is the first time human stem cells have been transplanted into mice in order to find RA ...
Progress reported in tackling initial, recurrent bouts of health care-associated infection
2012-10-04
CHICAGO — Surgeons are making progress toward preventing initial and recurrent episodes of clostridium difficile colitis (C. difficile or C. diff), a vicious bacterial infection that is estimated to affect about 336,000 people each year, typically patients on antibiotics. Using mouse models, researchers at the Massachusetts General Hospital (MGH), Boston, found that an oral medication may prevent C. difficile infections (CDI). Also, surgeons at Penn State University College of Medicine, Hershey, PA, examined human patients to detect a genetic mutation that could steer ...
New human neurons from adult cells right there in the brain
2012-10-04
VIDEO:
This is a direct observation of neuronal reprogramming of PDGFR-sorted pericyte-derived cells from the adult human brain by continuous live imaging in culture.
Note the change in morphology of a cell...
Click here for more information.
Researchers have discovered a way to generate new human neurons from another type of adult cell found in our brains. The discovery, reported in the October 5th issue of Cell Stem Cell, a Cell Press publication, is one step toward cell-based ...
Newborn mice depend on mom's signature scent
2012-10-04
VIDEO:
For newborn mice to suckle for the very first time and survive, they depend on a signature blend of scents that is unique to their mothers. The findings, published online...
Click here for more information.
For newborn mice to suckle for the very first time and survive, they depend on a signature blend of scents that is unique to their mothers. The findings, published online on October 4 in Current Biology, a Cell Press publication, reveal that mom's natural perfume consists ...
Botox as effective as medication for urinary urgency incontinence
2012-10-04
MAYWOOD – Botox® (onabotulinum toxin-A) injections to the bladder are as effective as medication for treating urinary urgency incontinence in women, but the injection is twice as likely to completely resolve symptoms. These findings were published in the latest issue of The New England Journal of Medicine by a National Institutes of Health clinical trials network including Loyola University Chicago Stritch School of Medicine (SSOM).
Urgency incontinence is urinary incontinence with a strong or sudden need to urinate. Traditionally, this condition has been treated with ...
Clot-busting enzymes are working 2 jobs
2012-10-04
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.
In research published today in Cell Reports, scientists from Monash University have demonstrated for the first time the enzyme t-PA, which plays a vital role in the removal of blood clots, is also a major player in the removal of necrotic, or dead, cells.
Necrosis occurs when cells in living tissue die prematurely due to external stress or injury. The body's system for removing waste ...
The smell of Mom: Scientists find elusive trigger of first suckling in mice
2012-10-04
LA JOLLA, CA – A team led by biologists at The Scripps Research Institute has solved the long-standing scientific mystery of how mice first know to nurse or suckle.
This basic mammalian instinct, which could be a key to understanding instinctive behavior more generally, was thought to be triggered by a specific odor (pheromone) that all mouse mothers emit. But, as described online ahead of print by the journal Current Biology on October 4, 2012, the trigger in mice turns out to be a more complicated blend of nature and nurture: a signature mix of odors, unique for each ...
In cancer, an embryonic gene-silencing mechanism gone awry
2012-10-04
There are some genes that are only activated in the very first days of an embryo's existence. Once they have accomplished their task, they are shut down forever, unlike most of our genes, which remain active throughout our lives. EPFL scientists have unveiled part of this strange mechanism. The same process, accidentally initiated later in life, could be responsible for many kinds of cancer. The discovery is described in a recent article in the journal Cell Reports.
The researchers identified a group of proteins that play a key role in this phenomenon. They bind to a ...
BWH researchers discover genetic risk for uterine fibroids
2012-10-04
BOSTON, MA—Uterine fibroids are the most common type of pelvic tumors in women and are the leading cause of hysterectomy in the United States. Researchers from Brigham and Women's Hospital (BWH) are the first to discover a genetic risk allele (an alternative form of a gene) for uterine fibroids in white women using an unbiased, genome-wide approach. This discovery will pave the way for new screening strategies and treatments for uterine fibroids.
The study will be published online on October 4, 2012 in The American Journal of Human Genetics.
The research team, led by ...
LAST 30 PRESS RELEASES:
BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors
Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC
Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds
Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy
NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC
EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC
Training to improve memory
Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?
Black youth, especially Black girls, use mental health services less than their White peers
Canada must protect youth from sports betting advertising
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
[Press-News.org] OU researchers implement a multi-photon approach in quantum cryptographyInformation breach may be drastically reduced as a result of a technology breakthrough